The association between diabetes and cognitive changes during aging.
Diabetes
cognitive functions
decline
elderly
systematic review
Journal
Scandinavian journal of primary health care
ISSN: 1502-7724
Titre abrégé: Scand J Prim Health Care
Pays: United States
ID NLM: 8510679
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
pubmed:
12
8
2020
medline:
19
8
2021
entrez:
12
8
2020
Statut:
ppublish
Résumé
Worldwide, we are observing a rising prevalence of dementia and mild cognitive impairments that often co-occur with the heightened incidence of non-communicable diseases in the elderly. It is suggested that type 2 diabetes and defects in glucose metabolism might predispose to poorer cognitive performances and more rapid decline in old age. to address existing knowledge gaps in this area, we systematically reviewed the literature to identify whether patients with type 2 diabetes (T2DM) and pre-diabetes are at a higher risk of poorer cognitive performance, and whether the risk (if any) might affect specific cognitive abilities. We concentrated the review on elderly individuals (65 years or older) at intake. In total, 3251 original articles were retrieved, of which 17 met our inclusion and quality control criteria, which comprised 12 structured questions used to define the articles. 11 of 17 studies found a statistically significant decline in cognition among individuals who had T2DM or pre-diabetes compared to their non-diabetic counterparts. The association between diabetes and cognitive decline was not always clear, and the extent of the cognitive tests used seemed to have the greatest effect on the results. Focusing on a population age 65 years and over, we found insufficient evidence to support an association between pre-diabetes stages and mild cognitive impairment. However, there is consistent evidence to support diabetes as an independent risk factor for low cognitive ability in the elderly. Finally, we found insufficient evidence to support effect of T2DM on distinct cognitive ability due to the scarcity of comparable findings.
Sections du résumé
BACKGROUND
BACKGROUND
Worldwide, we are observing a rising prevalence of dementia and mild cognitive impairments that often co-occur with the heightened incidence of non-communicable diseases in the elderly. It is suggested that type 2 diabetes and defects in glucose metabolism might predispose to poorer cognitive performances and more rapid decline in old age.
METHODS
METHODS
to address existing knowledge gaps in this area, we systematically reviewed the literature to identify whether patients with type 2 diabetes (T2DM) and pre-diabetes are at a higher risk of poorer cognitive performance, and whether the risk (if any) might affect specific cognitive abilities. We concentrated the review on elderly individuals (65 years or older) at intake. In total, 3251 original articles were retrieved, of which 17 met our inclusion and quality control criteria, which comprised 12 structured questions used to define the articles.
RESULTS
RESULTS
11 of 17 studies found a statistically significant decline in cognition among individuals who had T2DM or pre-diabetes compared to their non-diabetic counterparts. The association between diabetes and cognitive decline was not always clear, and the extent of the cognitive tests used seemed to have the greatest effect on the results.
CONCLUSION
CONCLUSIONS
Focusing on a population age 65 years and over, we found insufficient evidence to support an association between pre-diabetes stages and mild cognitive impairment. However, there is consistent evidence to support diabetes as an independent risk factor for low cognitive ability in the elderly. Finally, we found insufficient evidence to support effect of T2DM on distinct cognitive ability due to the scarcity of comparable findings.
Identifiants
pubmed: 32777967
doi: 10.1080/02813432.2020.1802140
pmc: PMC7470088
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
281-290Références
Neurosci Biobehav Rev. 2009 Mar;33(3):394-413
pubmed: 19026680
J Am Geriatr Soc. 2015 Jun;63(6):1075-83
pubmed: 26096383
BMJ. 2004 Mar 6;328(7439):548
pubmed: 14980984
Dement Geriatr Cogn Dis Extra. 2017 Nov 8;7(3):366-373
pubmed: 29282409
Neuroscience. 2013 Oct 10;250:140-50
pubmed: 23867771
N Engl J Med. 2013 Apr 4;368(14):1326-34
pubmed: 23550670
J Womens Health (Larchmt). 2011 Oct;20(10):1435-43
pubmed: 21819251
J Epidemiol Community Health. 2017 Feb;71(2):115-120
pubmed: 27440936
Arch Neurol. 2012 Sep;69(9):1170-5
pubmed: 22710333
Aging Clin Exp Res. 2012 Aug;24(4):377-83
pubmed: 23238313
Nat Rev Endocrinol. 2018 Oct;14(10):591-604
pubmed: 30022099
J Clin Epidemiol. 2003 Jul;56(7):686-93
pubmed: 12921938
Biochim Biophys Acta Mol Basis Dis. 2017 May;1863(5):1078-1089
pubmed: 27567931
Alzheimer Dis Assoc Disord. 2015 Jul-Sep;29(3):206-12
pubmed: 25650694
Diabetes. 2010 Nov;59(11):2928-35
pubmed: 20713684
Age (Dordr). 2014 Apr;36(2):977-93
pubmed: 24402401
Can J Diabetes. 2017 Feb;41(1):114-119
pubmed: 27614804
Diabetologia. 2018 Sep;61(9):1946-1955
pubmed: 29860628
Alzheimers Dement. 2011 Jul;7(4):418-24
pubmed: 21784353
J Am Med Dir Assoc. 2017 Sep 1;18(9):807.e17-807.e29
pubmed: 28754516
JAMA Intern Med. 2015 Sep;175(9):1450-8
pubmed: 26052687
J Am Geriatr Soc. 2008 Jun;56(6):1028-36
pubmed: 18384580
Alzheimers Dement. 2019 Jan;15(1):25-33
pubmed: 30114414
Arch Gerontol Geriatr. 2017 Sep;72:39-44
pubmed: 28544945
Neurology. 2004 Aug 24;63(4):658-63
pubmed: 15326238
J Int Neuropsychol Soc. 2004 Jul;10(4):599-607
pubmed: 15327738
J Am Med Dir Assoc. 2014 Dec;15(12):924-8
pubmed: 25271193